[Treatment with implantable cardioverter-defibrillators. Experiences from Skejby hospital during the period 1989-1994]

https://arctichealth.org/en/permalink/ahliterature54685
Source
Ugeskr Laeger. 1996 Feb 19;158(8):1068-72
Publication Type
Article
Date
Feb-19-1996
Author
J C Nielsen
E H Christiansen
P T Mortensen
A K Pedersen
Author Affiliation
Hjertemedicinsk afdeling B, Skejby Sygehus, Arhus.
Source
Ugeskr Laeger. 1996 Feb 19;158(8):1068-72
Date
Feb-19-1996
Language
Danish
Publication Type
Article
Keywords
Adolescent
Adult
Aged
Defibrillators, Implantable
Denmark - epidemiology
English Abstract
Female
Follow-Up Studies
Humans
Male
Middle Aged
Tachycardia, Ventricular - mortality - physiopathology - therapy
Abstract
The aim of the present study was to evaluate survival and therapy for ventricular tachyarrhythmia in patients treated with implantable cardioverter-defibrillator (ICD)-implantation at Skejby Hospital. Seventy-two patients, of which 54 were male, have received an ICD since 1989. Mean (range) age was 54 (16-74) years. Forty-nine (68%) had ischaemic heart disease. The patients were followed for a median (range) of 14 (1/2-50) months. Kaplan-Meyer plots are presented for total mortality, cardiac mortality, sudden cardiac mortality, appropriate therapy, and therapy for life-threatening tachyarrhythmia. After one, two and three years respectively, mortality was respectively 13, 27, and 32%, cardiac mortality was 5, 19, and 24%, sudden cardiac mortality was 3, 6, and 12%, cumulative incidence of appropriate therapy was 56, 66, and 90%, and cumulative incidence of therapy for life-threatening tachyarrhythmia was 19, 29 and 52%. It is concluded, that the majority of patients treated with an ICD developed ventricular tachyarrhythmia and had appropriate or lifesaving ICD-therapy during follow-up.
PubMed ID
8638339 View in PubMed
Less detail